Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
1.750
+0.040 (2.34%)
At close: May 28, 2026, 4:00 PM EDT
1.770
+0.020 (1.14%)
After-hours: May 28, 2026, 5:06 PM EDT
Aldeyra Therapeutics Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Aldeyra Therapeutics stock has a consensus rating of "Buy" and an average price target of $7.60. The average 1-year stock price forecast is 334.29% higher than the current stock price, while the lowest is $2.00 (+14.29%) and the highest is $13 (+642.86%).
Price Target: $7.60 (+334.29%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Aldeyra Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 4 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Hold Reiterates $2 | Hold | Reiterates | $2 | +14.29% | May 11, 2026 |
| BTIG | BTIG | Buy Maintains $9 | Buy | Maintains | $9 | +414.29% | Mar 18, 2026 |
Financial Forecast
Revenue This Year
27.66M
Revenue Next Year
11.42M
from 27.66M
Decreased by -58.70%
EPS This Year
-0.47
from -0.56
EPS Next Year
-0.24
from -0.47
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 86.0M | 21.6M | |||||
| Avg | 27.7M | 11.4M | |||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | - | -21.8% | |||||
| Avg | - | -58.7% | |||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | -0.39 | -0.23 | |||||
| Avg | -0.47 | -0.24 | |||||
| Low | -0.63 | -0.24 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | - | - | |||||
| Avg | - | - | |||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.